Supplementary Figure S1 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas
Abstract
Figure S1. IHC analysis of AG-NF2-Men tumor sections for various NF2/merlin-regulated signaling molecules, cMYC, and CD163.
Fields of Study & Subjects
Meningioma and schwannoma management
Neurofibromatosis and Schwannoma Cases
Glioma Diagnosis and Treatment
Publication details
- Publication date
- 27 January 2026